CompletedNot Applicable

Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease

China157 participantsStarted 2016-01

Plain-language summary

Endoscopic Tri-Modal Imaging which combines Narrow-band Imaging(NBI), Autofluorescence Imaging (AFI) and White-light Imaging (WLI) could be used to identify the indistinct changes in the gut caused by reflux disease,either acid reflux or bile reflux, which make it possible to differentiate reflux disease from functional dyspepsia (FD).

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * symptoms suggestive of GERD or dyspepsia. * Presence of symptom for longer than 6 month * Provision of written informed consent Exclusion Criteria: * Any known upper GI disease, other than reflux esophagitis * Active or healing gastroduodenal ulcer (except scars) * History of esophageal or gastric surgery. * Clinically significant heart, lung, liver or kidney disease * Allergy to proton-pump inhibitor * Pregnancy

What they're measuring

Numbers of participants with abnormal endoscopic findings and positive Omeprazole tests

Timeframe: one month

Trial details

NCT IDNCT02685150

SponsorChinese PLA General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06

View on ClinicalTrials.gov More Gastroesophageal Reflux Disease trials